A carregar...
Dasatinib-induced nephrotic syndrome in a patient with chronic myelogenous leukemia: a case report
BACKGROUND: Dasatinib is a second-generation tyrosine kinase inhibitor that is indicated for the treatment of patients with chronic myeloid leukemia. Here, we report the case of a man with nephrotic syndrome that was caused by dasatinib. CASE PRESENTATION: A 40-year-old man with chronic myeloid leuk...
Na minha lista:
| Publicado no: | BMC Nephrol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6407224/ https://ncbi.nlm.nih.gov/pubmed/30845905 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-019-1273-6 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|